These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 9843337)
21. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Riall TS; Cameron JL; Lillemoe KD; Winter JM; Campbell KA; Hruban RH; Chang D; Yeo CJ Surgery; 2006 Nov; 140(5):764-72. PubMed ID: 17084719 [TBL] [Abstract][Full Text] [Related]
22. EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos). Alexander S; Bourke MJ; Williams SJ; Bailey A; Co J Gastrointest Endosc; 2009 Jan; 69(1):66-73. PubMed ID: 18725157 [TBL] [Abstract][Full Text] [Related]
23. Carcinoid tumors of the duodenum. Mullen JT; Wang H; Yao JC; Lee JH; Perrier ND; Pisters PW; Lee JE; Evans DB Surgery; 2005 Dec; 138(6):971-7; discussion 977-8. PubMed ID: 16360380 [TBL] [Abstract][Full Text] [Related]
24. [Surgical treatment and prognosis of primary duodenal carcinoma]. Qu H; Tian YT; Sun YM; Wang CF; Shan Y; Zhao DB; Zhao P Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):233-5. PubMed ID: 19615269 [TBL] [Abstract][Full Text] [Related]
25. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064 [TBL] [Abstract][Full Text] [Related]
26. Carcinoma of the duodenum. van Ooijen B; Kalsbeek HL Surg Gynecol Obstet; 1988 Apr; 166(4):343-7. PubMed ID: 3353832 [TBL] [Abstract][Full Text] [Related]
27. Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis. Katz MH; Bouvet M; Al-Refaie W; Gilpin EA; Moossa AR Hepatogastroenterology; 2004; 51(57):842-6. PubMed ID: 15143931 [TBL] [Abstract][Full Text] [Related]
28. Resection of benign duodenal neoplasms. Kemp CD; Russell RT; Sharp KW Am Surg; 2007 Nov; 73(11):1086-91. PubMed ID: 18092639 [TBL] [Abstract][Full Text] [Related]
29. Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. Struck A; Howard T; Chiorean EG; Clarke JM; Riffenburgh R; Cardenes HR J Surg Oncol; 2009 Aug; 100(2):144-8. PubMed ID: 19544358 [TBL] [Abstract][Full Text] [Related]
31. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Abrahams NA; Halverson A; Fazio VW; Rybicki LA; Goldblum JR Dis Colon Rectum; 2002 Nov; 45(11):1496-502. PubMed ID: 12432298 [TBL] [Abstract][Full Text] [Related]
32. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice]. Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442 [TBL] [Abstract][Full Text] [Related]
33. Tumors of the ampulla of vater: histopathologic classification and predictors of survival. Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049 [TBL] [Abstract][Full Text] [Related]
34. [Malignant neoplasia of the small intestine. Apropos of 7 cases. Clinical discussion and review of the literature]. Bianchi E; De Monti M; Miani S; Stringhi E; Scorza R Minerva Chir; 1998 Apr; 53(4):289-98. PubMed ID: 9701984 [TBL] [Abstract][Full Text] [Related]
35. Analysis of small bowel tumors. Abdul-Rahman MM; Al-Waali MM; Al-Naaimi AS Saudi Med J; 2004 Dec; 25(12):1900-5. PubMed ID: 15711663 [TBL] [Abstract][Full Text] [Related]
36. [Adenocarcinoma of the duodenal bulb. A clinical case report]. Panichi S; Dell'Anna G; Palomba A; Colagrande S; Taruffi F Minerva Chir; 1998 Nov; 53(11):947-51. PubMed ID: 9973799 [TBL] [Abstract][Full Text] [Related]
37. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610 [TBL] [Abstract][Full Text] [Related]
38. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate. Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483 [TBL] [Abstract][Full Text] [Related]